Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-12-28 Purchase | 2024-01-02 6:00 pm | Longeveron Inc. | LGVN | Baluch Khoso Director | 10,000 | $1.4257 | $14,257 | 15,000 (Direct) | View |
2020-08-13 Purchase | 2020-08-17 6:45 pm | CorMedix Inc. | CRMD | Baluch Khoso Chief Executive Officer | 4,830 | $4.1377 | $19,985 | 661,135 (Direct) | View |
2020-03-18 Purchase | 2020-03-18 4:25 pm | CorMedix Inc. | CRMD | Baluch Khoso Chief Executive Officer | 3,500 | $2.61 | $9,135 | 656,305 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-03 Option Award | 2024-09-18 4:47 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 31,206 | $0 | 31,206 (Direct) | View |
2024-08-15 Option Award | 2024-08-19 8:30 pm | N/A N/A | Longeveron Inc. | LGVN | Baluch Khoso Director | 23,500 | $0 | 38,375 (Direct) | View |
2024-06-09 Tax Withholding | 2024-06-11 5:00 pm | N/A N/A | Longeveron Inc. | LGVN | Baluch Khoso Director | 125 | $1.06 | 14,875 (Direct) | View |
2023-12-21 Option Award | 2023-12-26 6:00 pm | N/A 2033-12-21 | Longeveron Inc. | LGVN | Baluch Khoso Director | 12,000 | $0 | 12,000 (Direct) | View |
2023-06-27 Option Award | 2023-07-24 6:29 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 101,365 | $0 | 129,320 (Direct) | View |
2023-06-27 Exercise | 2023-07-24 6:29 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 15,455 | $0 | 129,320 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 5:15 pm | N/A N/A | Longeveron Inc. | LGVN | Baluch Khoso Director | 5,000 | $0 | 5,000 (Direct) | View |
Ownership | 2023-06-12 5:00 pm | N/A N/A | Longeveron Inc. | LGVN | Baluch Khoso Director | 0 | $0 | 0 (Direct) | View |
2023-02-09 Option Award | 2023-02-10 5:18 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 12,500 | $0.8 | 12,500 (Direct) | View |
2022-07-12 Option Award | 2022-07-14 4:24 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 19,091 | $0 | 19,091 (Direct) | View |
2021-01-11 Option Award | 2021-01-13 8:07 pm | N/A 2031-01-11 | CorMedix Inc. | CRMD | Baluch Khoso Chief Executive Officer | 320,000 | $0 | 981,135 (Direct) | View |
2020-02-25 Option Award | 2020-02-27 9:46 pm | N/A 2030-02-25 | CorMedix Inc. | CRMD | Baluch Khoso Chief Executive Officer | 100,630 | $5.63 | 652,805 (Direct) | View |